Bfsg, LLC Catalyst Pharmaceuticals, Inc. Transaction History
Bfsg, LLC
- $998 Million
- Q3 2025
A detailed history of Bfsg, LLC transactions in Catalyst Pharmaceuticals, Inc. stock. As of the latest transaction made, Bfsg, LLC holds 161,106 shares of CPRX stock, worth $3.45 Million. This represents 0.32% of its overall portfolio holdings.
Number of Shares
161,106
Previous 161,621
0.32%
Holding current value
$3.45 Million
Previous $3.51 Million
9.52%
% of portfolio
0.32%
Previous 0.41%
Shares
5 transactions
Others Institutions Holding CPRX
# of Institutions
384Shares Held
103MCall Options Held
0Put Options Held
277K-
Black Rock Inc. New York, NY18.7MShares$400 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.71MShares$186 Million0.0% of portfolio
-
State Street Corp Boston, MA5.48MShares$117 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny3.25MShares$69.5 Million0.1% of portfolio
-
Morgan Stanley New York, NY3.18MShares$68.1 Million0.0% of portfolio
About CATALYST PHARMACEUTICALS, INC.
- Ticker CPRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 102,820,000
- Market Cap $2.2B
- Description
- Catalyst Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on developing and commercializing therapies for people with rare debilitating, chronic neuromuscular, and neurological diseases in the United States. It offers Firdapse, an amifampridine phosphate tablets for the treatment of patients with lambert-eaton myasthe...